News

Interval cancers, incidentalomas, the losers of screening

A letter from Ameli (French Health Insurance)

Screening: it is urgent to improve the information for women

Caution of the Council of European Union regarding screenings extension

The short news of October 2022

The new INCa 2022 booklet on breast cancer screening

A new EU approach to cancer screening

Liquid biopsies, the Grail?

The risks of screening: an elephant in the room

Potential benefits, as well as harms, from the COVID-19 disruption on cancer screening

Update on Tomosynthesis

When marketing, finance, lobbying, and advertising invite themselves into the health care sector